Jolstedt, Maral http://orcid.org/0000-0002-9427-295X
Vigerland, Sarah http://orcid.org/0000-0002-6788-3317
Mataix-Cols, David http://orcid.org/0000-0002-4545-0924
Ljótsson, Brjánn http://orcid.org/0000-0001-8086-1668
Wahlund, Tove http://orcid.org/0000-0002-5123-2392
Nord, Martina http://orcid.org/0000-0002-7023-9012
Högström, Jens http://orcid.org/0000-0002-5313-8498
Öst, Lars-Göran http://orcid.org/0000-0002-4351-2810
Serlachius, Eva http://orcid.org/0000-0001-7115-6422
Funding for this research was provided by:
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (Forte 2014-4052)
Stockholms Läns Landsting (HNSV 14099)
Karolinska Institute
Article History
Received: 2 October 2019
Accepted: 12 September 2020
First Online: 22 September 2020
Compliance with ethical standards
:
: MJ, SV and ES are the developers of the BiP Anxiety treatment protocol. BL is a Shareholder in DahliaQomit AB. DM-C received personal fees from UpToDate and Elsevier; grants from NIMH, Vetenskapsradet, Jane and Dan Olsson Foundation, Hjarnfonden and NIHR UK. All other authors have declared no competing or potential conflict of interest.